A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05

Clinical trial NCT05387083 · COMPLETED

Trial details

NCT number: NCT05387083
Sponsor: Tarsus Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2022-12-12
Primary completion: 2024-06-26
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.